Canada markets open in 1 hour 48 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
107.07-0.21 (-0.20%)
At close: 04:00PM EDT
107.33 +0.26 (+0.24%)
Pre-Market: 07:25AM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
5,723,000
5,723,000
6,933,000
7,071,000
4,495,000
Depreciation & amortization
3,243,000
3,243,000
3,267,000
3,538,000
3,327,000
Stock based compensation
644,000
644,000
685,000
640,000
546,000
Change in working capital
-2,475,000
-2,475,000
-1,519,000
-771,000
-892,000
Accounts receivable
-356,000
-356,000
-68,000
-383,000
-924,000
Inventory
-232,000
-232,000
-1,413,000
-456,000
-493,000
Accounts Payable
-760,000
-760,000
420,000
1,288,000
1,766,000
Other working capital
5,059,000
5,059,000
7,804,000
8,648,000
5,724,000
Net cash provided by operating activites
7,261,000
7,261,000
9,581,000
10,533,000
7,901,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,202,000
-2,202,000
-1,777,000
-1,885,000
-2,177,000
Acquisitions, net
-877,000
-877,000
0
-187,000
-42,000
Purchases of investments
-159,000
-159,000
-185,000
-173,000
-83,000
Sales/Maturities of investments
43,000
43,000
152,000
77,000
10,000
Other investing activites
22,000
22,000
22,000
26,000
19,000
Net cash used for investing activites
-3,133,000
-3,133,000
-1,740,000
-2,008,000
-2,215,000
Cash flows from financing activities
Debt repayment
-2,498,000
-2,498,000
-753,000
-48,000
-1,333,000
Common stock repurchased
-1,227,000
-1,227,000
-3,795,000
-2,299,000
-403,000
Dividends Paid
-3,556,000
-3,556,000
-3,309,000
-3,202,000
-2,560,000
Other financing activites
-
-
-
-
-11,000
Net cash used privided by (used for) financing activities
-7,091,000
-7,091,000
-7,636,000
-5,494,000
-2,779,000
Net change in cash
-2,986,000
-2,986,000
83,000
2,961,000
2,978,000
Cash at beginning of period
9,882,000
9,882,000
9,799,000
6,838,000
3,860,000
Cash at end of period
6,896,000
6,896,000
9,882,000
9,799,000
6,838,000
Free Cash Flow
Operating Cash Flow
7,261,000
7,261,000
9,581,000
10,533,000
7,901,000
Capital Expenditure
-2,202,000
-2,202,000
-1,777,000
-1,885,000
-2,177,000
Free Cash Flow
5,059,000
5,059,000
7,804,000
8,648,000
5,724,000